Related Experiment Video
Updated: Aug 30, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
MenoPAUSE: taking a second look at the role of HRT
1Philadelphia College of Pharmacy, University of the Sciences, Philadelphia, USA.
Abstract:
HRT should not be used for prevention of cardiovascular and coronary artery disease. While estrogen plays a role in osteoporosis, the bisphosphonates and raloxifene demonstrate equal or superior efficacy for prevention and treatment, compared with HRT. HRT decreases the risk of colon cancer but increases a woman's chance of developing breast cancer. Short-term use of low-dose HRT remains a valid option for management of menopausal symptoms, especially hot flushes. Pharmacists can help patients interpret the information in the press and guide them in weighing the risks and benefits as they evaluate HRT for use in their own individual situations.
Related Concept Videos
Menopause
Hormonal Regulation
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Bone Remodeling
Mitral Valve Prolapse II: Assessment and Management